| scholarly article | Q13442814 |
| P50 | author | Yosef A Berlow | Q90407710 |
| Saptarshi Chakraborty | Q90407714 | ||
| P2093 | author name string | H Lee Sweeney | |
| Dah-Jyuu Wang | |||
| Michael J Daniels | |||
| William D Rooney | |||
| Claudia Senesac | |||
| Glenn A Walter | |||
| Krista Vandenborne | |||
| Sean C Forbes | |||
| Donovan J Lott | |||
| Richard Finkel | |||
| Rebecca J Willcocks | |||
| Barry S Russman | |||
| Gihan Tennekoon | |||
| Elliott O'Brien | |||
| Erika L Finanger | |||
| Ishu Arpan | |||
| William T Triplett | |||
| Harneet Arora | |||
| Brendan Moloney | |||
| Alison Barnard | |||
| P2860 | cites work | Dystrophin: the protein product of the Duchenne muscular dystrophy locus | Q29618077 |
| Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy | Q30546319 | ||
| Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle | Q30665063 | ||
| Quantitative Skeletal Muscle MRI: Part 2, MR Spectroscopy and T2 Relaxation Time Mapping-Comparison Between Boys With Duchenne Muscular Dystrophy and Healthy Boys | Q30982305 | ||
| Magnetic resonance imaging of skeletal muscle disease | Q31115497 | ||
| Notch signaling deficiency underlies age-dependent depletion of satellite cells in muscular dystrophy. | Q33935640 | ||
| Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS. | Q34171004 | ||
| Human soleus muscle: a comparison of fiber composition and enzyme activities with other leg muscles | Q34205271 | ||
| A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy | Q34417832 | ||
| Muscular dystrophies and the dystrophin-glycoprotein complex | Q34425741 | ||
| Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies | Q34518069 | ||
| The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy | Q36842039 | ||
| Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort. | Q37114363 | ||
| MRI quantifies neuromuscular disease progression | Q37123866 | ||
| Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy | Q37633713 | ||
| Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy | Q37975308 | ||
| Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy. | Q38865431 | ||
| Pharmacological advances for treatment in Duchenne muscular dystrophy | Q39293658 | ||
| Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy | Q42368601 | ||
| Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure | Q43454569 | ||
| High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy. | Q44239685 | ||
| Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy | Q45410633 | ||
| Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. | Q45935564 | ||
| Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. | Q45966003 | ||
| Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up | Q46750138 | ||
| Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. | Q48560409 | ||
| A short protocol for muscle MRI in children with muscular dystrophies. | Q53667939 | ||
| Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy. | Q55282480 | ||
| Necroptosis mediates myofibre death in dystrophin-deficient mice | Q58759838 | ||
| Report on the workshop: Meaningful outcome measures for Duchenne muscular dystrophy, London, UK, 30–31 January 2017 | Q59876191 | ||
| Long-term benefit from prednisone therapy in Duchenne muscular dystrophy | Q67767537 | ||
| The muscular dystrophies | Q77731754 | ||
| Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy | Q85398934 | ||
| P921 | main subject | Duchenne muscular dystrophy | Q1648484 |
| P577 | publication date | 2020-03-17 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Modeling disease trajectory in Duchenne muscular dystrophy |
Search more.